PUNE, India, December 22, 2017 —
Kidney/Renal Function Test Market is forecast to reach $790.1 million by 2022 from $586.5 million in 2017 at a CAGR of 6.1% during (2017-2022) driven by the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and the rise in alcohol consumption.
Browse 90 Market Data Tables and 33 Figures spread through 126 Pages and in-depth TOC on “Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User – Global Forecast to 2022 http://www.reportsnreports.com/reports/1260107-kidney-renal-function-test-market-by-product-dipsticks-reagents-disposables-type-urine-test-urine-protein-microalbumin-creatinine-clearance-blood-test-serum-creatinine-bun-end-user-global-forecast-to-2022.html
The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).
The kidney function tests market in Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2017-2022. Factors such as the region's rising geriatric population, increasing incidence of non-communicable diseases, and the growing number of conferences and campaigns to create awareness regarding kidney diseases are key factors driving market growth.
Inquire for DISCOUNT on “Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User – Global Forecast to 2022“ research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1260107
By type, the kidney function tests market is segmented into urine and blood tests. In 2017, the urine tests segment is expected to account for the largest share of the kidney function tests market. The increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood tests and the limited risk of infection during sample collection is factors driving the growth of this segment.
On the basis of product, the Kidney/Renal Function Test Market is segmented into dipsticks, reagents, and disposables. The dipsticks segment is expected to account for the largest share of the market in 2017. The large share and high-growth rate of this product segment can be attributed to the cost-effectiveness of dipstick testing and its widespread application in healthcare.
North America is expected to account for the largest share of the global kidney function/renal function test market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market.
Order a copy of “Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User – Global Forecast to 2022“ research report at http://www.reportsnreports.com/purchase.aspx?name=1260107
The report provides a picture of the kidney function tests market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Break of primary participants was as mentioned below:
- By Company Type: Tier I – 55%, Tier II – 25%, Tier III – 20%
- By Designation: C-Level Executives – 43%, Directors – 32%, Others – 25%
- By Region: North America – 38%, Europe – 23%, Asia-Pacific – 29%, RoW – 10%
Another research titled Urology Devices Market Global Forecast to 2022 says, the global urology devices market is expected to reach $44.37 billion by 2022 from $31.44 billion in 2017, at a CAGR of 7.1%. The urological cancer and BPH disease segment is anticipated to grow at the fastest growth rate during the forecast period. The hospitals and clinics segment is estimated to grow at a rapid rate during the forecast period. Asia is estimated to grow at the highest CAGR during the forecast period. Companies such as Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier Med Tech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), Biolitec (Germany) have been profiled in this 167 pages research report available at http://www.reportsnreports.com/purchase.aspx?name=732385
Explore more reports on Medical Devices Market at http://www.reportsnreports.com/market-research/medical-devices/
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune – 411001.
Connect with Us:
Powered by WPeMatico